Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
PLLA Dermal Filler
Ingredient: Poly-l-lactic acid 50%, Sodium carboxymethyl cellulose, Mannitol
Specification: 150mg, 180mg,350mg
Package: Bottle
Application Area: Combined to make water and light, tighten and lift the skin, stimulate collagen, fill wrinkles and so on.
Product Introduction：
The use of highly uniform microspheres minimizes inflammation and lowers the incidence of redness and swelling at the injection site. Irradiation sterilization is a safer and more predictable method compared to EO sterilization, which may leave residues. The higher molecular weight of the product supports a slower degradation process, ensuring long-lasting and natural skin enhancement.
Product Display：
Product Details:
Type | |
Ingredient | Hyaluronic 26mg/ml, hydroxyapatite 30% |
Specification | 150mg, 180mg,350mg |
Effect area | Different uses, different layers |
Application area | Combined to make water and light, tighten and lift the skin, stimulate collagen, fill wrinkles and so on |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Bottle |
Storage | Cool, dry environment |
Recommended | 1-2 pc/time |
Recommended interval | 12-24 months |
Lasting time | 12-24 months |
Microsphere size | More uniform particle size; D10 is greater than 10μm |
Characteristic viscosity | 1.2-1.4dL/g |
Product Package:
Customer Feedback：
Raw Material Advantages：
PLLA Lyophilized Product H-Type: This product contains cross-linked sodium hyaluronate, providing an immediate filling effect upon injection and reducing the volume loss that can occur after some time. As the sodium hyaluronate gradually degrades, the microspheres in the formula continuously stimulate collagen production in the skin, ensuring long-lasting skin improvement. Additionally, the product helps to brighten the complexion.
Development Process:
Company Introduction:
The PCL/PLLA synthesis technology we employ guarantees low tin content (Sn <30 ppm), precise molecular weight control, and medical-grade biocompatibility, leveraging self-developed synthesis equipment for anhydrous, oxygen-free, kilogram-scale production. Moreover, our purification technology enables the refinement of industrial-grade materials into sterile, pyrogen-free medical-grade substances such as sodium hyaluronate, carboxymethyl starch, and carboxymethyl cellulose.
